alexa An Uncommon Case of Atypical Fibroxanthoma of the Bulbar Conjunctiva | OMICS International
ISSN: 2155-9570
Journal of Clinical & Experimental Ophthalmology

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

An Uncommon Case of Atypical Fibroxanthoma of the Bulbar Conjunctiva

Katherine Suman1*, Matthew Cossack1, Mahendra Rupani1, Komal Desai1, Jordan Colson2 and Soheila Hamidpour2

1Department of Ophthalmology, University of Missouri, Kansas City, MO 64108, USA

2Department of Pathology, University of Missouri, Kansas City, MO 64108, USA

*Corresponding Author:
Katherine Suman
Department of Ophthalmology
University of Missouri, Kansas City
University Health 2101 Charlotte Street, MO 64108, USA
Tel: 816-404-1780
E-mail: [email protected]

Received Date: June 05, 2017; Accepted Date: June 27, 2017; Published Date: June 30, 2017

Citation: Suman K, Cossack M, Rupani M, Desai K, Colson J, et al. (2017) An Uncommon Case of Atypical Fibroxanthoma of the Bulbar Conjunctiva. J Clin Exp Ophthalmol 8:660. doi: 10.4172/2155-9570.1000660

Copyright: © 2017 Suman K, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Clinical & Experimental Ophthalmology

Abstract

An Atypical Fibroxanthoma (AFX) is a benign skin tumor of mesenchymal origin most commonly found on the sun-exposed or radiation-damaged skin of the elderly. AFX may share many common histologic and clinical characteristics with squamous cell carcinoma and melanoma; however, it is a benign process. Therefore, differentiating between these lesions is important. Differences in histologic features and patterns of immunohistochemical staining for CD68, CD10, cytokeratins, S-100 and Fi-67 may diagnose AFX. The presence of an AFX on the conjunctiva is rare with only five other reported cases. We report a case of AFX that developed in the bulbar conjunctiva near the limbus.

Keywords

Atypical fibroxanthoma; Malignant fibrous histiocytoma

Case Study

A 58 year old Caucasian male was referred to our ocular oncology clinic for suspected conjunctival intraepithelial neoplasia of the right eye. Over four months, he noted growth of a conjunctival mass. The tissue began clear but grew to become more “flesh-like” and lobulated. The mass was associated with conjunctival injection, irritation, and epiphora. The patient denied pain with extraocular movements, blurry vision and diplopia. His visual acuity was normal and color vision was intact.

On slit lamp examination a nodular papillomatous lesion was noted on the right nasal conjunctiva, abutting the limbus, with associated injection (Figure 1).

clinical-ophthalmology-atypical-bulbar

Figure 1: Gross image of an atypical fibroxanthoma of the bulbar conjunctiva.

The assessment was a malignant neoplasm of the right conjunctiva, likely squamous cell carcinoma. An excisional conjunctival biopsy was taken and histologic sections were made. Double freeze-thaw cryotherapy was applied to the base of the lesion immediately following excision. Tissue was then sent for permanent section to pathology. Haemotoxylin and Eosin staining was conducted to characterize the cell types present. Immunohistochemical staining with antibodies against CD68, CD10, Ki67, pan cytokeratin and S-100 was also completed using different sections of the biopsy.

Histopathology slides revealed a relatively well-circumscribed lesion within the conjunctiva (Figure 2A).

clinical-ophthalmology

Figure 2a: H & E 4X.

The tumor was composed of highly atypical spindle and epithelioid cells focally surrounded by hyalinized stroma; thus, revealing many atypical mitotic figures (Figure 2B).

clinical-ophthalmology-spindle-hyaline

Figure 2b: H & E 40 X, spindle and epithelioid cells with interstitial hyaline fibrosis and scattered multinucleated cells and atypical cells with mitotic figures.

Immunohistochemical staining showed that the tumor cells were positive for CD68 (Figure 2C) and CD10 (Figure 2D) and had high mitotic activity by Ki67 (Figure 2E).

clinical-ophthalmology-tumor-cells

Figure 2c: CD68 40X, Majority of tumor cells are positive for CD68.

clinical-ophthalmology-cytoplasmic-positive

Figure 2d: CD10 40X, tumor cells show membranous and occasional cytoplasmic positive.

clinical-ophthalmology-proliferation-rate

Figure 2e: Ki67 40X, tumor cells show high proliferation rate.

The cells were negative for Pan cytokeratin and S-100 (Figure 2F). A diagnosis of atypical fibroxanthoma was made.

clinical-ophthalmology-tumor-cells

Figure 2f: S100 20X, scattered dendritic cells are stained by S100.

Discussion

This is the sixth reported case of AFX of the bulbar conjunctiva. Of the five other reported cases, four were found at the limbus, as in our patient [1-4]. The typical histologic presentation of AFX is spindle, plump, epithelioid and bizarre cells, in various proportions, arranged in haphazard, vaguely fascicular or storiform patterns [4]. Often, there is fibroblastic, myofibroblastic, and epithelioid cells with pleomorphism noted [5]. Some cells of the lesion may contain vacuolated and lipid-containing cytoplasm similar to a xanthoma [4]. Most of the reported cases of conjunctival AFX have been either spindle-cell predominant or pleomorphic with epithelioid and multinucleated giant cells [1]. Here we see some of these features including spindle-shaped cells, multinucleated giant cells and epithelioid cells, without a predominant cell type (Figure 2B).

Immunohistochemical staining is an important step in diagnosing AFX. The Ki-67 index is high in this tumor, relating to the rapidgrowing nature of this tumor (Figure 2E). S-100 is positive in malignant melanoma. However, dendritic/Langerhans cells within AFX may express S-100 (Figure 2F) [4]. Cytokeratin is positive in squamous cell carcinoma but not AFX. This negative stain is not depicted. A histiocytic/macrophage marker, CD68, is positive in more than half of all AFX cases (Figure 2C). However, D68 is also detectable in 86% of malignant melanoma cases [4]. Therefore, this marker can rule out squamous cell carcinoma but not melanoma. CD10 is positive in 95-100% of AFX (Figure 2D). It is reported that about one third of melanomas and half of squamous cell carcinomas are also positive for CD10. However, melanomas and squamous cell carcinomas stained weakly, with majority accumulating in the stroma [4]. When using immunohistochemical staining to diagnose AFX it is important to known these possible variations.

Many consider atypical fibroxanthoma as a superficial variant of Malignant Fibrous Histiocytoma (MFH), which is known to have an aggressive growth pattern with significant metastatic potential. The two are identical histologically featuring fibrohistiocytic lesions with myofibroblastic differentiation [4]. However, AFX is located in the dermis while MFH can be found within the subcutaneous fat, with perineural and lymphovascular invasion [5]. No case of metastatic conjunctival AFX has been reported. It is thought that any case of metastatic AFX of the skin was misdiagnosed MFH [6]. Likewise, any case of a metastatic soft tissue tumor of the conjunctiva has been reported as MFH [7,8].

This case of AFX had similarities and differences when compared to other reported cases in the literature. The location near the limbus was similar to four out of five cases of bulbar conjunctival AFX. While 33% of previously reported cases were associated with Xeroderma Pigmentosum (XP) [5], our case was not. Although AFX of the skin is associated with sun exposure or radiation damage in the elderly, now 42% of cases of AFX of the conjunctiva are found in patients under 60 years old without XP. The physical appearance, rapid growth period, and symptoms of irritation and epiphora were similar to previously reported cases [1]. The histologic appearance of our case was different from others in that there was no predominant cell type identified within the lesion.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Article Usage

  • Total views: 461
  • [From(publication date):
    June-2017 - Jun 24, 2018]
  • Breakdown by view type
  • HTML page views : 418
  • PDF downloads : 43
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7